Antitumor properties of a new macrocyclic tetranuclear oxidovanadium(v) complex with 3-methoxysalicylidenvaline ligand

HIGHLIGHTS

• who: Mihaela Turtoi et al. from the Department of Inorganic Chemistry, Faculty of Chemistry, University of Bucharest, Dumbrava Rosu0327ie have published the research work: Antitumor Properties of a New Macrocyclic Tetranuclear Oxidovanadium(V) Complex with 3-Methoxysalicylidenvaline Ligand, in the Journal: Biomedicines 2022, 1217 of 15/04/2022
• what: The authors aimed to develop a new vanadium-based drug and assess its antitumor properties using the human hepatocarcinoma (HepG2) cell line. The studies demonstrate the potent antitumor activity of_[(VV O)(L)(CH3 O)]4 and propose it as an attractive candidate for anticancer therapy . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.